09/06/21 -"Our target price hike is largely attributable to an increase in our peer-based valuations, as we have factored in a premium of 20% vs none earlier. We believe, given the recovery from the quality ..."
Pages
60
Language
English
Published on
09/06/21
You may also be interested by these reports :
04/11/25
Philips’ Q3 profitability exceeded expectations. Comparable top-line growth was driven by robust performance in Personal Health and Connected Care. ...
04/11/25
FMC posted strong Q3 results, driven by cost savings and growth across segments, thereby helping to reiterate the 2025 outlook. Despite the results ...
31/10/25
Drägerwerk’s delivered solid Q3 2025 numbers. Revenue rose 10.1% to €833 million, driving a substantial 370bps EBIT margin expansion to 6.8%. This, ...
30/10/25
Amplifon’s Q3 results did not meet the company-compiled consensus. Sales growth was supported by strong performance in the Americas and a recovery in ...